Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
about
From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transportA review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control.Targets for current pharmacologic therapy in cholesterol gallstone disease.Consensus statement on management of dyslipidemia in Indian subjects.A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy.Therapy of gallstone disease: What it was, what it is, what it will beTherapeutic targeting of bile acidsLipid Control before CABG and Its Association with In-Hospital Mortality.Fish oil and indomethacin in combination potently reduce dyslipidemia and hepatic steatosis in LDLR(-/-) mice.The case for more intensive use of statins.Grape Seed Procyanidins and Cholestyramine Differentially Alter Bile Acid and Cholesterol Homeostatic Gene Expression in Mouse Intestine and Liver.Statin use and all-cause and cancer mortality: BioBank Japan cohort.My Approach to the Patient With Familial Hypercholesterolemia.Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome.Pharmacological strategies for lowering LDL cholesterol: statins and beyond.Inhibition of cholesterol absorption: targeting the intestine.Diagnosis and management of familial dyslipoproteinemias.A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Pharmacotherapies for lipid modification: beyond the statins.The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol.Cholesterol-lowering efficacy of Lactobacillus plantarum CECT 7527, 7528 and 7529 in hypercholesterolaemic adults.Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6-24 weeks.Pharmacological Evaluation of Novel Isonicotinic Carboxamide Derivatives as Potential Anti-Hyperlipidemic and Antioxidant Agents.Increasing the Bile Acid Sequestration Performance of Cationic Hydrogels by Using an Advanced/Controlled Polymerization Technique.LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease
P2860
Q26997647-BB6D2902-922C-4209-9954-D488027DE867Q33942724-D7E95848-F7FB-420B-A4D3-88AC25F411B4Q34036014-B0B2F116-3B9A-485D-96AD-C4DAC943D7D2Q34041538-72787287-32D1-4F7E-9A95-C684A4EC0763Q34980772-C59C0DA9-9006-476D-AC46-51A127229AA4Q35683911-6D7874FF-05A2-4ABA-8A2D-3DFA08882F2CQ35948819-7F98C623-3062-46AB-98A7-D1FCE1932EDAQ35958534-60CD1C8A-EE49-458D-87BA-A3C52717D708Q36022286-FF72FA79-D128-4AD7-A668-4C56E03B35AFQ36213911-5C465322-6EC5-42ED-A632-3588F535028DQ36515517-F850B5D9-8B46-4810-96FF-B78D015AA4E4Q36833239-6CC7236F-79CF-4E7F-8599-FDFFA1D87E24Q37700224-EBBE77FF-05DC-4965-A591-49A2AF51B678Q37731770-BEB870C3-DAF8-480B-92B2-59E5D82C2288Q37756954-CDBD5D3E-FF7C-4F67-B294-4033877394B0Q37842120-DAB09247-1C78-4FC3-A46E-30F167C05869Q38038125-9ADA009D-11E9-4470-A24F-26ABCF4D71FBQ38105993-40849F62-BA84-491B-B995-CAC396B04F1EQ38113494-564230F0-7EFB-4730-B999-CFD680F619A3Q38130111-265D7B39-A7D0-437B-A29F-2D3D77C720EEQ38151675-1164A63E-DCEC-4435-A4C3-C4755A4773BDQ43616696-B0FC9627-004D-4567-8F3A-6F6D6427AA55Q44166893-5F68D470-C3EC-44E8-AA11-43873A2EC80CQ46316753-F08A9075-B390-46E2-8041-D5833516135FQ48010887-32664388-05D6-49E2-B7CC-0B833C8B9EE9Q57316348-E66C08A3-1316-44AE-B031-953C7558929E
P2860
Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lowering low-density lipoprote ...... mparative efficacy and safety.
@en
Lowering low-density lipoprote ...... mparative efficacy and safety.
@nl
type
label
Lowering low-density lipoprote ...... mparative efficacy and safety.
@en
Lowering low-density lipoprote ...... mparative efficacy and safety.
@nl
prefLabel
Lowering low-density lipoprote ...... mparative efficacy and safety.
@en
Lowering low-density lipoprote ...... mparative efficacy and safety.
@nl
P1476
Lowering low-density lipoprote ...... mparative efficacy and safety.
@en
P2093
Anne Carol Goldberg
Runhua Hou
P356
10.1016/J.ECL.2008.11.007
P577
2009-03-01T00:00:00Z